Drugs / MNI-340
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00968097 | Apr → Jul 2008 | Alzheimer disease | Institute for Neurodegenerative Disorders | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNI-340 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00968097 ↗ |
| Modality | Diagnostic / imaging agent | “as a single photon computed tomography (SPECT) brain imaging agent” NCT00968097 ↗ |
| Route | Intravenous | “Subjects will be given a bolus injection of 123-I MNI-340 in an antecubital vein.” NCT00968097 ↗ |